NCT00203476: A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction |
|
|
| Completed | 4 | 30 | US | Niacin, Colestipol, Ezetimibe, Zetia | Tuscaloosa Research & Education Advancement Corporation, American Society of Health-System Pharmacists Research and Education Foundation | Hyperlipidemia, Hypercholesterolemia | 01/08 | 01/08 | | |
